Baolan Li

2.3k total citations
35 papers, 868 citations indexed

About

Baolan Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Baolan Li has authored 35 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Baolan Li's work include Lung Cancer Research Studies (16 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Baolan Li is often cited by papers focused on Lung Cancer Research Studies (16 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Baolan Li collaborates with scholars based in China, United States and Germany. Baolan Li's co-authors include Mingming Hu, Ying Hu, Jiabei He, Zhehai Wang, Yi Luo, Kai Li, Yuankai Shi, Baohui Han, Ying Cheng and Jianying Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Baolan Li

35 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baolan Li China 12 613 325 218 174 119 35 868
Jiachen Xu China 17 562 0.9× 357 1.1× 256 1.2× 208 1.2× 122 1.0× 51 1.0k
Peijian Peng China 14 558 0.9× 385 1.2× 183 0.8× 142 0.8× 152 1.3× 26 834
Satoshi Muto Japan 18 406 0.7× 311 1.0× 246 1.1× 229 1.3× 223 1.9× 72 898
Valeria Merz Italy 16 445 0.7× 179 0.6× 353 1.6× 135 0.8× 186 1.6× 36 851
Marco Puzzoni Italy 16 438 0.7× 174 0.5× 213 1.0× 102 0.6× 159 1.3× 50 737
Vito Vanella Italy 16 709 1.2× 145 0.4× 328 1.5× 267 1.5× 87 0.7× 34 997
Francesca Simionato Italy 17 455 0.7× 199 0.6× 290 1.3× 111 0.6× 199 1.7× 31 794
Rilan Bai China 13 567 0.9× 247 0.8× 240 1.1× 306 1.8× 171 1.4× 36 920
Wen Liu China 15 525 0.9× 210 0.6× 407 1.9× 94 0.5× 182 1.5× 59 885

Countries citing papers authored by Baolan Li

Since Specialization
Citations

This map shows the geographic impact of Baolan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baolan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baolan Li more than expected).

Fields of papers citing papers by Baolan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baolan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baolan Li. The network helps show where Baolan Li may publish in the future.

Co-authorship network of co-authors of Baolan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Baolan Li. A scholar is included among the top collaborators of Baolan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baolan Li. Baolan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yanxia, Baolan Li, Ying Wang, et al.. (2025). Dose-dependent efficacy of CX1003 in NSCLC immunotherapy: High dose for T cell response, low dose for apoptosis. International Immunopharmacology. 165. 115520–115520. 1 indexed citations
2.
3.
4.
Zhao, Cong, Tong Li, Bin Liu, et al.. (2023). Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer. BMC Cancer. 23(1). 973–973. 2 indexed citations
5.
6.
7.
Zhao, Cong, Zhiyun Zhang, Xingsheng Hu, et al.. (2022). Hyaluronic Acid Correlates With Bone Metastasis and Predicts Poor Prognosis in Small-Cell Lung Cancer Patients. Frontiers in Endocrinology. 12. 785192–785192. 10 indexed citations
8.
Zhang, Tongmei, Lína Zhang, Yuan Gao, et al.. (2021). Role of aneuploid circulating tumor cells and CD31 + circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC. Molecular Oncology. 15(11). 2891–2909. 24 indexed citations
9.
10.
Liu, Guimei, Tongmei Zhang, Jiaqiang Huang, et al.. (2020). Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma. Radiology and Oncology. 55(1). 66–76. 4 indexed citations
11.
Wang, Ying, Yanxia Liu, Lína Zhang, et al.. (2019). Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer. Journal of Cancer Research and Clinical Oncology. 145(12). 2911–2920. 41 indexed citations
12.
Han, Baohui, Kai Li, Yizhuo Zhao, et al.. (2018). Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302). British Journal of Cancer. 118(5). 654–661. 195 indexed citations
13.
Hu, Aimin, Dan Zhao, Hua Zheng, et al.. (2016). Preoperative Diagnosis in 46 Cases of Pulmonary Sclerosing Hemangioma. Chinese Medical Journal. 129(11). 1377–1378. 13 indexed citations
14.
Zheng, Hua, et al.. (2016). Trichomegaly and scalp hair changes following treatment with erlotinib in pulmonary adenocarcinoma patients: A case report and literature review. Experimental and Therapeutic Medicine. 12(3). 1287–1292. 9 indexed citations
15.
Zhang, Tongmei, Qunhui Wang, Ying Hu, et al.. (2016). [Clinical analysis of 6 pulmonary blastoma patients].. PubMed. 38(1). 39–41. 2 indexed citations
16.
17.
Hu, Mingming, et al.. (2015). Primary adenoid cystic carcinoma of the lung: Clinicopathological features, treatment and results. Oncology Letters. 9(3). 1475–1481. 41 indexed citations
18.
He, Jiabei, Ying Hu, Mingming Hu, & Baolan Li. (2015). Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer. Scientific Reports. 5(1). 13110–13110. 319 indexed citations
19.
Li, Jie, Yi Han, Zhidong Liu, et al.. (2014). Association between VEGFR-3 expression and lymph node metastasis in non-small-cell lung cancer. Experimental and Therapeutic Medicine. 9(2). 389–394. 12 indexed citations
20.
Li, Baolan, et al.. (2014). Protective effects of scoparone against lipopolysaccharide-induced acute lung injury. International Immunopharmacology. 23(1). 127–133. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiachen Xu Breakdown of academic impact, for papers by Peijian Peng Breakdown of academic impact, for papers by Satoshi Muto Breakdown of academic impact, for papers by Valeria Merz Breakdown of academic impact, for papers by Marco Puzzoni Breakdown of academic impact, for papers by Vito Vanella Breakdown of academic impact, for papers by Francesca Simionato Breakdown of academic impact, for papers by Rilan Bai Breakdown of academic impact, for papers by Wen Liu
Rankless by CCL
2026